2026 POLICY UPDATE: Vaccine Schedule Restructured

On January 5, 2026, the Department of Health and Human Services (HHS) announced significant changes to the U.S. adult immunization schedule, reducing universal vaccine recommendations and introducing three categories: Routine (Universal), High-Risk Based, and Shared Clinical Decision-Making (SCDM).

Several adult vaccines were moved from Universal to SCDM status, including COVID-19, Influenza, Hepatitis A, Hepatitis B, and Meningococcal. Under SCDM, vaccination decisions are made between the doctor and patient based on individual health history and risk profile — not a universal age-based requirement.

Important context: These changes were implemented outside the standard ACIP public review process. The American Academy of Pediatrics (AAP), the Infectious Diseases Society of America (IDSA), and over 200 health organizations have stated they continue to recommend all affected vaccines for appropriate adult patients. Insurance coverage for SCDM vaccines remains required under existing federal law.

Evidence Label: Documented Official Policy Change | Contested Process | Genuine Scientific/Policy Debate

U.S. Adult Vaccination Schedule

CDC recommendations for adults 19 years and older by age and risk factors.

Key Adult Vaccines

  • Influenza: Annual
  • Tdap/Td: One dose Tdap, then Td booster every 10 years
  • COVID-19: Updated 2024-2025 vaccine for all adults
  • Shingrix (shingles): Adults 50+ (2 doses)
  • Pneumococcal: Adults 65+ or high-risk
  • Meningococcal: Certain risk groups
  • Hepatitis B: Risk-based
  • HPV: Through age 26 (shared decision 27-45)
  • MMR: If lacking evidence of immunity
  • Varicella: If lacking immunity

Related Pages